Antares Pharma OverviewAntares Pharma EBIT
EBIT (Earnings Before Interest and Taxes) analysis for ATRS.
Quarterly EBIT
-$2.82M
↓ 152.31% YoY
As of Mar 31, 2022
Annual EBIT (TTM)
$19.13M
↓ 6.13% YoY
Trailing 12 months ending Mar 31, 2022
Antares Pharma OverviewEBIT (Earnings Before Interest and Taxes) analysis for ATRS.
As of Mar 31, 2022
Trailing 12 months ending Mar 31, 2022